The anti-proliferative effect of TI1B, a major Bowman–Birk isoinhibitor from pea (Pisum sativum L.), on HT29 colon cancer cells is mediated through protease inhibition

Bowman-Birk Inhibitors from Legumes and Human Gastrointestinal Health: Current Status and Perspectives

(2011) Alfonso Clemente et al.   CURRENT PROTEIN & PEPTIDE SCIENCE

Recombinant antimicrobial peptide hPAB-β expressed in Pichia pastoris, a potential agent active against methicillin-resistant Staphylococcus aureus

(2010) Zhijin Chen et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Role of Thiols and Disulfides on Protein Stability

(2009) Maulik Trivedi et al.   CURRENT PROTEIN & PEPTIDE SCIENCE

Bowman-Birk inhibitors in lentil: Heterologous expression, functional characterisation and anti-proliferative properties in human colon cancer cells

(2009) Pasqua Caccialupi et al.   FOOD CHEMISTRY

The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases

(2009) Alfonso Clemente et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Anti-carcinogenic soyabean Bowman–Birk inhibitors survive faecal fermentation in their active form and do not affect the microbiota composition in vitro

(2008) M. Carmen Marín-Manzano et al.   BRITISH JOURNAL OF NUTRITION

Identification and characterization of a Bowman–Birk inhibitor active towards trypsin but not chymotrypsin in Lupinus albus seeds

(2008) Alessio Scarafoni et al.   PHYTOCHEMISTRY

Active Bowman–Birk inhibitors survive gastrointestinal digestion at the terminal ileum of pigs fed chickpea-based diets

(2007) Alfonso Clemente et al.   JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE